Agile Therapeutics Inc (fka AGRX)

[Invest-in-America]

AGRX: THANKS!!! (A little 'DD', below.)

https://www.globenewswire.com/news-release/2022/06/28/2470534/0/en/Healthcare-Breakthroughs-KZR-NMLSF-AGRX-LMLLF-Report-Latest-Advances-in-Novel-Therapeutics-for-Inflammatory-Diseases-Oncology-and-Autism.html

https://www.twirla.com/

"Agile Therapeutics (NASDAQ: AGRX), a women's healthcare company, reported increasing Twirla prescription data for the first quarter 2022.Twirla cycles dispensed increased 29% to 16,602; Total prescriptions (TRx) increased 27% to 12,494; Refills (RRx) increased 31% to 7,143; New prescriptions (NRx) increased 22% to 5,351; Total prescribers increased 26% to 5,837. CEO Al Altomari commented: “We believe we have a brand that is building steady growth momentum, which we saw continue in the prescription demand data for the first quarter 2022. This growth is consistent with what we reported for the fourth quarter 2021 and we continue to believe we are seeing signs of a healthy, growing brand."